Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Lipocine Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +22 vs. Q4 2025
- Shares held
- 3.12M
- +1.71M (+121.5%) vs. Q4 2025
- Total value
- $24.9M
- +$13.6M (+120.3%) vs. Q4 2025
- New holders
- 24
- 9 more added
- Sold out
- 2
- 10 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 508,556 | $4.06M | 0.58% | +309,014+154.9% | Added |
| Squadron Capital Management LLC | 450,000 | $3.60M | 1.44% | −80,000−15.1% | Reduced |
| Eversept Partners, LP | 294,989 | $2.36M | 0.16% | +294,989 | New |
| Rosalind Advisors, Inc. | 221,616 | $1.77M | 0.73% | +221,616 | New |
| Vanguard Capital Management LLC | 200,668 | $1.60M | 0.00% | +200,668 | New |
| AIGH Capital Management LLC | 200,000 | $1.60M | 0.33% | +200,000 | New |
| StemPoint Capital LP | 160,420 | $1.28M | 0.25% | +160,420 | New |
| Boothbay Fund Management, LLC | 140,487 | $1.12M | 0.03% | +85,594+155.9% | Added |
| Seven Fleet Capital Management LP | 124,942 | $998.3K | 0.31% | +124,942 | New |
| Birchview Capital, LP | 111,786 | $893.2K | 0.51% | +111,786 | New |
| BlackRock, Inc. | 89,272 | $713.3K | 0.00% | 00.0% | Unchanged |
| Mink Brook Asset Management LLC | 66,812 | $533.8K | 0.30% | +66,812 | New |
| Geode Capital Management, LLC | 63,135 | $504.7K | 0.00% | +685+1.1% | Added |
| Exome Asset Management LLC | 60,861 | $486.3K | 0.29% | +60,861 | New |
| Diadema Partners LP | 50,000 | $399.5K | 0.16% | −210,939−80.8% | Reduced |
| J. Goldman & Co LP | 42,170 | $336.9K | 0.02% | +42,170 | New |
| Renaissance Technologies LLC | 38,497 | $307.6K | 0.00% | +1,100+2.9% | Added |
| Two Sigma Investments, LP | 33,750 | $269.7K | 0.00% | +33,750 | New |
| Vanguard Fiduciary Trust Co | 32,413 | $259.0K | 0.00% | +32,413 | New |
| Citadel Advisors LLC | 29,088 | $232.4K | 0.00% | +29,088 | New |
| Susquehanna International Group, LLP | 24,908 | $199.0K | 0.00% | −10.0% | Reduced |
| ADAR1 Capital Management, LLC | 23,180 | $185.2K | 0.01% | +23,180 | New |
| State Street Corp | 22,407 | $179.0K | 0.00% | +3,781+20.3% | Added |
| Jane Street Group, LLC | 20,027 | $160.0K | 0.00% | +9,453+89.4% | Added |
| Dimensional Fund Advisors LP | 19,122 | $152.8K | 0.00% | +6,982+57.5% | Added |
| XTX Topco Ltd | 17,923 | $143.2K | 0.00% | +17,923 | New |
| Persistent Asset Partners Ltd | 13,442 | $107.4K | 0.04% | −57,134−81.0% | Reduced |
| Northern Trust Corp | 13,042 | $104.2K | 0.00% | −118−0.9% | Reduced |
| Prelude Capital Management, LLC | 12,630 | $100.9K | 0.01% | +12,630 | New |
| Ameriprise Financial Inc | 11,448 | $91.5K | 0.00% | −4,656−28.9% | Reduced |
| Barclays PLC | 9,412 | $75.2K | 0.00% | +9,412 | New |
| UBS Group AG | 3,494 | $27.9K | 0.00% | −2,109−37.6% | Reduced |
| Wells Fargo & Company | 2,706 | $21.6K | 0.00% | +2,706 | New |
| Vanguard Global Advisers, LLC | 1,691 | $13.5K | 0.00% | +1,691 | New |
| Tower Research Capital LLC (TRC) | 933 | $7.46K | 0.00% | +933 | New |
| FMR LLC | 626 | $5.00K | 0.00% | +549+713.0% | Added |
| Morgan Stanley | 574 | $4.59K | 0.00% | −177−23.6% | Reduced |
| Caldwell Sutter Capital, Inc. | 471 | $3.76K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 392 | $2.97K | 0.00% | +392 | New |
| Advisor Group Holdings, Inc. | 143 | $1.14K | 0.00% | +25+21.2% | Added |
| Group One Trading, L.P. | 132 | $1.05K | 0.00% | −30−18.5% | Reduced |
| PlanVest Financial, Inc | 111 | $887 | 0.00% | +111 | New |
| SBI Securities Co., Ltd. | 67 | $535 | 0.00% | 00.0% | Unchanged |
| Tidemark, LLC | 59 | $471 | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 3 | $24 | 0.00% | +3 | New |
| Farther Finance Advisors, LLC | 1 | $9 | 0.00% | +1 | New |
| Royal Bank of Canada | 50 | $0 | 0.00% | −23−31.5% | Reduced |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |